CompanyDrug

Luye Pharma Launches Toludesvenlafaxine in China for Depression Treatment

R&D

Hong Kong Researchers Identify New Target for Epilepsy Treatment

CompanyDrug

Hope Medicine Gains Global Approval for Phase II Trial of HMI-115

CompanyDeals

Full-Life Technologies Acquires Focus-X Therapeutics to Expand Pipeline

Policy / Regulatory

NMPA Launches Electronic Certificates for API and Pharmaceutical Product Exports

CompanyDeals

I-Mab Partners with Wuxi Diagnostics to Advance Biomarker-Driven Clinical Studies

CompanyDeals

Trinomab Biotech Raises RMB 750 Million in Pre-IPO Financing Round

Company

Alibaba Health Reports 22.9% Revenue Growth in H1 2022

CompanyDeals

3D Medicines Set for IPO in Hong Kong, Aiming to Raise Up to USD 55 Million

CompanyPolicy / Regulatory

China’s Medical Product Trade Surplus Declines Amid COVID-19 Impact

CompanyDeals

Nuance Pharma Partners with DKSH to Launch Bentrio Nasal Spray in Hong Kong and Macau

Deals

Biocytogen and ADC Therapeutics Enter Evaluation and Option Agreement